Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · IEX Real-Time Price · USD
0.301
-0.018 (-5.58%)
At close: Mar 28, 2024, 4:00 PM
0.295
-0.006 (-2.03%)
After-hours: Mar 28, 2024, 6:46 PM EDT
Allarity Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for ALLR.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ALLR.
Recommendation Trends
Rating | Jun '22 | Jul '22 | Aug '22 |
---|---|---|---|
Strong Buy | 1 | 1 | 0 |
Buy | 0 | 0 | 0 |
Hold | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 |
Total | 1 | 1 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 23, 2022 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $11,200 | Strong Buy | Initiates | $11,200 | +3,719,594.45% | May 27, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
49.54M
EPS This Year
-0.57
from -10.26
EPS Next Year
-0.60
from -0.57
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | n/a | 51.0M | 104.8M | 161.4M |
Avg | n/a | 49.5M | 101.8M | 156.8M |
Low | n/a | 47.6M | 97.8M | 150.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | 111.5% | 58.6% |
Avg | - | - | 105.4% | 54.1% |
Low | - | - | 97.4% | 48.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -0.59 | -0.62 | -0.92 | -0.86 |
Avg | -0.57 | -0.60 | -0.90 | -0.84 |
Low | -0.55 | -0.58 | -0.86 | -0.80 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | - |
Avg | - | - | - | - |
Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.